Scientific News: Oppenheimer Questions $14.5B Penumbra Deal Valuation Despite Boston Scientific’s (BSX) Mew Market Dominance

Choose a language:

Science Daily Reports

Details: Written by Bing News Search Results; Category: Science Daily Reports; Published: 24 January 2026; Created: 24 January 2026; Last Updated: 24 January 2026

Boston Scientific Corporation (NYSE:BSX) is one of the best mid-cap growth stocks to buy right now. On January 16, Oppenheimer lowered its price target on Boston Scientific to $100 from $125 with an ...
Original Image Link
Source:www.msn.com

Posted: 2026-01-23 07:58:58

Get Full News Story On Bing Science News Network

Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.

More News From This Category
Scientific News: Made Scientific and Regenicin Announce Manufacturing Relationship to Advance NovaDerm Toward FDA Product Approval
Wed, 22 Apr 2026 22:07:15 +0000

Made Scientific, Inc., a U.S.-based cell therapy contract development and manufacturing organization (CDMO), and Regenicin, Inc., a biotechnology company specializing in the development and ...
Original Image Link
Source:finance.yahoo.com

Scientific News: Core Scientific Sells $3.3 Billion Of Bonds To Fund Data Centre Pivot
Wed, 22 Apr 2026 22:07:15 +0000

Core Scientific (NASDAQ: $CORZ) is planning to raise $3.3 billion U.S. through a junk bond sale as it pivots toward artificial intelligence (A.I.) data centres. The bond sale comes after Core ...
Original Image Link
Source:finance.yahoo.com

Scientific News: Boston Scientific cuts 2026 profit forecast, trims revenue growth view
Wed, 22 Apr 2026 19:07:15 +0000

April 22 () - Medical device maker Boston Scientific cut its annual profit forecast on Wednesday, overshadowing a first-quarter earnings and revenue ‌beat, while its shares were little changed after ...
Original Image Link
Source:www.aol.com

Scientific News: Boston Scientific (NYSE:BSX) Surprises With Q1 CY2026 Sales
Wed, 22 Apr 2026 19:07:15 +0000

Medical device company Boston Scientific (NYSE:BSX) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 11.6% year on year to $5.20 billion. On the other hand, next ...
Original Image Link
Source:finance.yahoo.com

Scientific News: Boston Scientific cuts 2026 profit forecast, trims revenue growth view
Wed, 22 Apr 2026 16:07:14 +0000

Related Bing News Results